Back to Search Start Over

Major histocompatibility complex (MHC) gene frequency in acquired dermal macular hyperpigmentation: a case control study.

Authors :
Vinay K
Kamat D
Narayan R V
Minz RW
Singh J
Bishnoi A
Chatterjee D
Parsad D
Kumaran MS
Source :
International journal of dermatology [Int J Dermatol] 2024 Jun; Vol. 63 (6), pp. 773-779. Date of Electronic Publication: 2024 Jan 23.
Publication Year :
2024

Abstract

Background: Human leukocyte antigen (HLA) allele frequencies have a known association with the pathogenesis of various autoimmune diseases.<br />Methods: We recruited 31 Indian patients of acquired dermal macular hyperpigmentation (ADMH) and 60 unrelated, age-and-gender-matched healthy controls. After history and clinical examination, 5 ml of blood in EDTA vials was collected. These samples were subjected to DNA extraction and the expression of HLA A, B, C, DR, DQ-A, and DQ-B was studied.<br />Results: There was a predominance of females with a gender ratio of 23 : 8 and the most common phototype was Fitzpatrick type IV (83.9%). There was a significant association of HLA A*03:01 (OR: 5.8, CI: 1.7-17.0, P = 0.005), HLA B*07:02 (OR: 5.3, CI: 1.9-14.6, P = 0.003), HLA C*07:02 (OR: 4.3, CI: 1.8-9.6, P = 0.001), HLA DRB1*10:01 (OR: 7.6, CI: 1.7-38.00, P = 0.022), and HLA DRB1*15:02 (OR: 31.0, CI: 4.4-341.8, P < 0.001) with patients compared to controls, whereas HLA DQB*03:01 was less associated with patients compared to controls (OR: 0.2, CI: 0.0-0.6, P = 0.009).<br />Conclusion: Patients with ADMH are more likely to have the HLA A*03:01, HLA B 07*02, HLA C*07:02, HLA DRB1*10:01, HLA DRB1*15:02 and less likely to have the HLA DQB*03:01 allele. Larger cohort studies may thus be conducted studying these specific alleles.<br /> (© 2024 the International Society of Dermatology.)

Details

Language :
English
ISSN :
1365-4632
Volume :
63
Issue :
6
Database :
MEDLINE
Journal :
International journal of dermatology
Publication Type :
Academic Journal
Accession number :
38263574
Full Text :
https://doi.org/10.1111/ijd.17017